心脏骤停幸存者神经功能恢复程度与初始神经元特异性烯醇化酶水平及脑电图模式的关系:一项双中心研究
该双中心队列研究分析了2017–2024年966例心脏骤停后昏迷患者,至少有一次48小时血清NSE和≥24小时EEG。NSE分为<17、17–<41、41–60、>60 µg/L四组,EEG分为高度恶性、恶性、良性。主要终点为3个月CPC评分。结果显示NSE水平和EEG模式在CPC组间差异显著(p<0.001),NSE越高、EEG越严重,功能结局越差;幸存者中亦如此。NSE>60 µg/L者中,CPC 1有2/176例(1.2%,最高79.5 µg/L),CPC 2有3/138例(2.2%,最高68 µg/L),均无其他不良预后标志;CPC 1或2者中无高度恶性EEG。
要点
- 966例心脏骤停后昏迷患者中,48小时NSE水平越高,3个月CPC功能结局越差(p<0.001),幸存者中亦显著。
- EEG模式越严重(高度恶性>恶性>良性),3个月功能结局越差(p<0.001)。
- NSE>60 µg/L者中仍有个别达到CPC 1(2/176,1.2%,最高79.5 µg/L)或CPC 2(3/138,2.2%,最高68 µg/L),均无其他不良预后标志。
- 达到CPC 1或2的患者中,无一例为高度恶性EEG。
- 作者认为NSE和EEG可能有助于预测幸存者的认知损害。
适用人群与场景
- 心脏骤停后昏迷患者,来自CHUV洛桑(瑞士)和科雄医院(法国)两个前瞻性登记数据库。
- 纳入条件:至少有一次48小时血清NSE和≥24小时EEG。
诊断标准与关键阈值
- NSE分类:<17 µg/L、17≤NSE<41 µg/L、41≤NSE≤60 µg/L、>60 µg/L。
- EEG分类:高度恶性、恶性、良性。
- 主要结局:3个月神经功能恢复程度,采用脑功能分类(CPC)量表。
研究设计与关键结果
- 双中心队列研究,纳入2017–2024年966例心脏骤停后昏迷患者。
- 48小时NSE水平范围在CPC组间差异显著,NSE越高功能结局越差;幸存者(CPC1 vs CPC2 vs CPC3)中亦显著(p<0.001)。
- EEG模式在CPC组间差异显著,EEG模式越严重功能结局越差(p<0.001)。
- NSE>60 µg/L者中,达到CPC 1者2/176例(1.2%,最高79.5 µg/L),达到CPC 2者3/138例(2.2%,最高68 µg/L),均无其他不良预后标志。
- CPC 1或2者中无高度恶性EEG。
证据类型、等级与局限
- 证据类型:双中心前瞻性登记队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为NSE和EEG可能有助于预测心脏骤停幸存者的认知损害。
- NSE>60 µg/L且无其他不良预后标志的患者中仍有个别达到CPC 1或2,仅凭NSE>60 µg/L不足以断定不良预后。
- 高度恶性EEG未见于CPC 1或2患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The relationship between early markers of brain injury (biomarkers and EEG patterns) and the subsequent degree of neurological recovery in cardiac arrest survivors at 3 months has received little attention. We aimed to examine this relationship and describe patients who survived despite having initial unfavorable NSE levels and EEG patterns.
METHODS: Cohort study analysing two prospective registries (CHUV Lausanne, Switzerland; Cochin Hospital, France). We included comatose patients after cardiac arrest who had at least one serum NSE at 48 h and an EEG ≥ 24 h. NSE was classified as < 17 µg/L, 17 ≤ NSE < 41 µg/L, 41 ≤ NSE ≤ 60 µg/L or > 60 µg/L. EEG was classified as highly malignant, malignant or benign. The primary outcome was the level of neurological recovery at 3 months according to the Cerebral Performance Category (CPC) scale. NSE and EEG were compared between the CPC groups. We also assessed the number of patients with a CPC 1 or 2 and either an NSE > 60 µg/L or a highly malignant EEG.
RESULTS: Between 2017 and 2024, 966 comatose patients were included. The NSE level ranges at 48 h differed significantly across the CPC groups, higher values being associated with poorer functional outcomes; this significant difference was also notable in survivors (CPC1 vs CPC2 vs CPC3) (p < 0.001). EEG patterns were also significantly different across CPC groups: the more severe the EEG pattern, the worse the functional outcome (p < 0.001). Regarding false-positive prediction of unfavorable outcome, NSE > 60 µg/L was found in 2/176 patients (1.2 %) who reached CPC 1 (maximum at 79.5 µg/L) and 3/138 patients (2.2 %) who reached CPC 2 at follow up (maximum at 68 µg/L); none of them had other markers of unfavorable outcome. No patients with CPC 1 or 2 had a highly malignant EEG.
CONCLUSION: This large bicentric study found a progressive worsening of neurological outcomes at 3 months with higher NSE levels or deteriorating EEG patterns. Thus, both NSE and EEG may be valuable for predicting cognitive impairments in survivors. Only a few patients with favorable outcome had NSE levels > 60 µg/L, and none of them had other markers of unfavorable outcome.
参考来源
- Benghanem S, Novy J, Cariou A, et al. Degree of neurological recovery as a function of initial neuron-specific enolase levels and electroencephalographic patterns in survivors of cardiac arrest: a bicentric study. Resuscitation. 2025. PMID: 40780697. doi:10.1016/j.resuscitation.2025.110757
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。